Association between Hepatitis A seropositivity and bone mineral density in adolescents and adults: a cross-sectional study using NHANES data
Palavras-chave:
Adolescents, Adults, Multivariable regression, Osteoporosis, Bone density, Hepatitis A, Seroepidemiologic studies, Nutrition surveysResumo
BACKGROUND: Osteoporosis, characterized by decreased bone density and increased fracture risk, imposes significant physical, psychosocial, and financial burdens. Early detection and prevention are crucial for managing osteoporosis and reducing the risk of fractures. OBJECTIVES: To investigate the relationship between Hepatitis A seropositivity and bone mineral density (BMD) in adolescents and adults and to explore the potential link between Hepatitis A infection and osteoporosis risk. DESIGN AND SETTING: This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 to evaluate the association between hepatitis A seropositivity and BMD in 15,693 participants. METHODS: Multivariable regression analysis was used to calculate the mean BMD and standard error for adolescents and adults, followed by an independent z-test to determine whether there was a significant difference between the seropositive and seronegative groups. RESULTS: Hepatitis A seropositive adolescents and adults had lower BMD than their seronegative counterparts, with significant differences in lumber spine (mean difference = -0.03 g/cm2, P < 0.01 for both age groups) and pelvis BMDs (mean difference = -0.02 g/cm2, P < 0.01 for the adult age groups), after adjusting for various covariates. CONCLUSIONS: This study confirmed that both adolescent and adult individuals seropositive for Hepatitis A antibodies had reduced BMD among both adolescents and adults, especially in the adult group. This finding suggests a possible link between Hepatitis A infection and risk of osteoporosis.
Downloads
Referências
Blanchard R, Thomas CDL, Hardiman R, et al. Structural and Material Changes of Human Cortical Bone With Age: Lessons from the Melbourne Femur Research Collection. In: Narayan R, editor. Encyclopedia of Biomedical Engineering. Oxford: Elsevier; 2019. p. 246-264. https:// doi.org/10.1016/B978-0-12-801238-3.99928-8.
Ebeling PR, Nguyen HH, Aleksova J, et al. Secondary Osteoporosis. Endocr Rev. 2022;43(2):240-313. PMID: 34476488; https://doi.org/10.1210/ endrev/bnab028.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878-882. PMID: 10093980; https://doi.org/10.1016/s0140-6736(98)09075-8.
Prasad D, Nguyen MH. Chronic hepatitis, osteoporosis, and men: under-recognised and underdiagnosed. Lancet Diabetes Endocrinol. 2021;9(3):141. PMID: 33607040; https://doi.org/10.1016/s22138587(21)00020-6.
The Lancet Diabetes Endocrinology. Osteoporosis: overlooked in men for too long. Lancet Diabetes Endocrinol. 2021;9(1):1. PMID: 33285120. https://doi.org/10.1016/s2213-8587(20)30408-3.
NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785-795. PMID: 11176917; https://doi.org/10.1001/ jama.285.6.785.
Reid IR. Revisiting osteoporosis guidelines. Lancet Diabetes Endocrinol. 2021;9(12):805-806. PMID: 34688355; https://doi.org/10.1016/s22138587(21)00283-7.
Stevenson MO, Tangpricha V. Osteoporosis and Bone Health in Transgender Persons. Endocrinol Metab Clin North Am. 2019;48(2):421427. PMID: 31027549; https://doi.org/10.1016/j.ecl.2019.02.006.
Linder KA, Malani PN. Hepatitis A. JAMA. 2017;318(23):2393. PMID: 29094153; https://doi.org/10.1001/jama.2017.17244.
Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020;69(5):1-38. PMID: 32614811; https://doi.org/10.15585/mmwr.rr6905a1.
Centers for Disease Control and Prevention. Surveillance for viral hepatitis—United States. Available from: https://www.cdc.gov/ hepatitis/statistics/SurveillanceRpts.htm. Accessed in2023 (Oct. 24).
Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132(6):1005-1022. PMID: 15635957; https://doi.org/10.1017/s0950268804002857.
Jung YM, Park SJ, Kim JS, et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol. 2010;82(8):1318-1326. PMID: 20572083; https://doi.org/10.1002/ jmv.21822.
Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health. 2000;91(3):168-170. PMID: 10927841; https://doi.org/10.1007/bf03404264.
Baeg MK, Yoon SK, Ko SH, et al. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys. Hepatol Int. 2016;10(3):470-477. PMID: 26850597; https://doi.org/10.1007/s12072015-9672-7.
Dessordi R, Watanabe LM, Guimarães MP, et al. Bone loss in hepatitis B virus-infected patients can be associated with greater osteoclastic activity independently of the retroviral use. Sci Rep. 2021;11(1):10162. PMID: 33986322; https://doi.org/10.1038/s41598-021-89486-9.
Oh H, Jun DW, Lee IH, et al. Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B. Aliment Pharmacol Ther. 2020;52(2):371-381. PMID: 32542860; https:// doi.org/10.1111/apt.15867.
Zhang Y, Gao X, Liu T, et al. Association between osteoporosis and hepatitis B cirrhosis: a case-control study. Afr Health Sci. 2020;20(4):16101616. PMID: 34394221; https://doi.org/10.4314/ahs.v20i4.13.
Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Phatharacharukul P, Ungprasert P. Hepatitis C virus infection and risk of osteoporosis: A metaanalysis. Saudi J Gastroenterol. 2017;23(4):216-221. PMID: 28721974; https://doi.org/10.4103/sjg.SJG_452_16.
Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol. 1985;122(2):226-233. PMID: 3860002; https://doi.org/10.1093/ oxfordjournals.aje.a114093.
Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. Available from: https://www.cdc.
gov/nchs/nhanes/about_nhanes.htm. Accessed in 2023 (Oct. 24).
World Health Organization. Adolescent health. Available from: https:// www.who.int/health-topics/adolescent-health#tab=tab_1. Accessed in 2023 (Oct. 24).
Mayo Clinic. Menopause. Available from: https://www.mayoclinic.org/ diseasesconditions/menopause/symptoms-causes/syc-20353397. Accessed in 2023 (Oct. 24)..
Centers for Disease Control and Prevention. NHANES Body Composition Procedures Manual. 2018. Available from: https://wwwn.cdc.gov/nchs/ data/nhanes/2017-2018/manuals/Body_Composition_Procedures_ Manual_2018.pdf. Accessed in 2023 (Oct. 24).
Kanis JA, Johnell O, Oden A, et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000;11(8):669-674. PMID: 11095169; https:// doi.org/10.1007/s001980070064.
Centers for Disease Control and Prevention. Hepatitis A Antibody Laboratory Procedure Manual. 2019. Available from: https://wwwn.cdc. gov/nchs/data/nhanes/2017-2018/labmethods/HEPA-J-MET-HEPATITISA-ANTIBODY-508.pdf. Accessed in 2023 (Oct. 24)..
Ni G, van der Werf J, Zhou X, et al. Genotype-covariate correlation and interaction disentangled by a whole-genome multivariate reaction norm model. Nat Commun. 2019;10(1):2239. PMID: 31110177; https:// doi.org/10.1038/s41467-019-10128-w.
Sukegawa S, Fujimura A, Taguchi A, et al. Identification of osteoporosis using ensemble deep learning model with panoramic radiographs and clinical covariates. Sci Rep. 2022;12(1):6088. PMID: 35413983; https:// doi.org/10.1038/s41598-022-10150-x.
Centers for Disease Control and Prevention. Weighting. Available from: https://wwwn.cdc.gov/nchs/nhanes/tutorials/Weighting.aspx. Accessed in 2023 (Oct. 24).
Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. Cmaj. 2005;172(3):367-379. PMID: 15684121; https://doi. org/10.1503/cmaj.1040752.
Fierro NA, Castro-Garcia FP, Panduro A. Rethinking cytokine function during hepatitis A and hepatitis C infections. Advances in Bioscience and Biotechnology. 2013;4(7A):13-18. PMID; https://doi.org/10.4236/ abb.2013.47A1003.
XinHuan W, YaLi L, Jing Z, Wei L. Expression and significance of cytokines in children with acute hepatitis A. - Journal of Clinical Hepatology. 2019;35(9):1942. PMID; https://doi.org/-10.3969/j.issn.10015256.2019.09.011.
Shin EC, Sung PS, Park SH. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat Rev Immunol. 2016;16(8):509523. PMID: 27374637; https://doi.org/10.1038/nri.2016.69.
Jeong HM, Kim DJ. Bone Diseases in Patients with Chronic Liver Disease. Int J Mol Sci. 2019 Aug 31;20(17):4270. PMID: 31480433. https://doi.org/10.3390/ijms20174270.
Alexopoulos EC. Introduction to multivariate regression analysis. Hippokratia. 2010;14(Suppl 1):23-28. PMID: 21487487.
Xue S, Kemal O, Lu M, et al. Age at attainment of peak bone mineral density and its associated factors: The National Health and Nutrition Examination Survey 2005-2014. Bone. 2020;131:115163. PMID: 31760214; https://doi.org/10.1016/j.bone.2019.115163.
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973-997. PMID: 34448749; https://doi.
org/10.1097/gme.0000000000001831.
Zhu X, Zheng H. Factors influencing peak bone mass gain. Front Med. 2021;15(1):53-69. PMID: 32519297; https://doi.org/10.1007/s11684-0200748-y.
Gordon CM, Zemel BS, Wren TA, et al. The Determinants of Peak Bone Mass. J Pediatr. 2017;180:261-269. PMID: 27816219; https://doi. org/10.1016/j.jpeds.2016.09.056.
Wei MT, Le AK, Chang MS, et al. Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B. J Med Virol. 2019;91(7):1288-1294. PMID: 30776311; https://doi.org/10.1002/ jmv.25433.
Clements D, Rhodes J. Hormone replacement therapy in chronic active hepatitis; a case report. Gut. 1993;34(11):1639-1640. PMID: 8244156; https://doi.org/10.1136/gut.34.11.1639.
Danford CJ, Trivedi HD, Bonder A. Bone Health in Patients With Liver Diseases. J Clin Densitom. 2020;23(2):212-222. PMID: 30744928; https:// doi.org/10.1016/j.jocd.2019.01.004.
Nakchbandi IA, van der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(11):660-670. PMID: 19881518; https://doi.org/10.1038/ nrgastro.2009.166.
Schmidt T, Schmidt C, Strahl A, et al. A System to Determine Risk of Osteoporosis in Patients With Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2020;18(1):226-233.e223. PMID: 31163277; https://doi. org/10.1016/j.cgh.2019.05.043.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 São Paulo Medical Journal
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
